Cite
Malaab M, Renaud L, Takamura N, et al. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2021;81(2):268-277doi: 10.1136/annrheumdis-2021-221050.
Malaab, M., Renaud, L., Takamura, N., Zimmerman, K. D., da Silveira, W. A., Ramos, P. S., Haddad, S., Peters-Golden, M., Penke, L. R., Wolf, B., Hardiman, G., Langefeld, C. D., Medsger, T. A., & Feghali-Bostwick, C. A. (2022). Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Annals of the rheumatic diseases, 81(2), 268-277. https://doi.org/10.1136/annrheumdis-2021-221050
Malaab, Maya, et al. "Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis." Annals of the rheumatic diseases vol. 81,2 (2022): 268-277. doi: https://doi.org/10.1136/annrheumdis-2021-221050
Malaab M, Renaud L, Takamura N, Zimmerman KD, da Silveira WA, Ramos PS, Haddad S, Peters-Golden M, Penke LR, Wolf B, Hardiman G, Langefeld CD, Medsger TA, Feghali-Bostwick CA. Antifibrotic factor KLF4 is repressed by the miR-10/TFAP2A/TBX5 axis in dermal fibroblasts: insights from twins discordant for systemic sclerosis. Ann Rheum Dis. 2022 Feb;81(2):268-277. doi: 10.1136/annrheumdis-2021-221050. Epub 2021 Nov 08. PMID: 34750102; PMCID: PMC8758541.
Copy
Download .nbib